U.S. Office of Global Health Diplomacy should lead G20 efforts to ensure global NTD drug coverage

Published on March 27, 2013 at 5:36 AM · No Comments

"Because they strike mostly forgotten people living on less than $2 per day, [neglected tropical diseases (NTDs)] have traditionally been thought of as a problem exclusive to low-income countries, especially in sub-Saharan Africa," Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and president and director of the Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, writes in a Foreign Policy opinion piece. "But our latest research shows that most cases of the worst NTDs (defined by disability-adjusted life years lost) actually occur among the extreme poor who live in the large emerging market economies that comprise the G20, together with Nigeria, which has a GDP equivalent to several Western European countries," he notes, adding, "Much of the disease burden within G20 countries falls on the poor in Indonesia and the BRICS (Brazil, Russia, India, China, and South Africa), but there are also several serious NTDs found in Eastern and Southern Europe, and in the southern United States."

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post